D
Daniel A. Lawrence
Researcher at University of Michigan
Publications - 201
Citations - 13506
Daniel A. Lawrence is an academic researcher from University of Michigan. The author has contributed to research in topics: Plasminogen activator & Plasminogen activator inhibitor-1. The author has an hindex of 63, co-authored 187 publications receiving 12696 citations. Previous affiliations of Daniel A. Lawrence include Scripps Health & University of Maryland, Baltimore.
Papers
More filters
Journal ArticleDOI
The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin.
TL;DR: It is reported that vitronectin significantly enhances the migration of smooth muscle cells (SMCs), and that the specific VNR αvβ3 is required for cell motility, and that PAI-1 can control cell–matrix interactions by regulating the accessibility of specific cell-attachment sites.
Journal ArticleDOI
Tissue-type plasminogen activator induces opening of the blood-brain barrier via the LDL receptor-related protein.
Manuel Yepes,Maria Sandkvist,Elizabeth Moore,Thomas H. Bugge,Dudley K. Strickland,Daniel A. Lawrence +5 more
TL;DR: It is demonstrated that tPA is both necessary and sufficient to directly increase vascular permeability in the early stages of BBB opening, and suggested that this occurs through a receptor-mediated cell signaling event and not through generalized degradation of the vascular basement membrane.
Journal ArticleDOI
Purification of an inhibitor of plasminogen activator (antiactivator) synthesized by endothelial cells.
TL;DR: Results indicate that cultured bovine aortic endothelial cells synthesize and secrete a protein which inhibits plasminogen activators and is distinct from protease nexin, a major endothelial cell product, and, as such, probably plays an important role in regulating the fibrinolytic system of these cells.
Journal ArticleDOI
Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke
Enming J. Su,Linda Fredriksson,Melissa Geyer,Erika Folestad,Jacqueline M. Cale,Johanna Andrae,Johanna Andrae,Yamei Gao,Kristian Pietras,Kris M. Mann,Manuel Yepes,Dudley K. Strickland,Christer Betsholtz,Ulf Eriksson,Daniel A. Lawrence +14 more
TL;DR: It is demonstrated that PDGF signaling regulates blood-brain barrier permeability and suggest potential new strategies for stroke treatment through activation of PDGF-α receptors on perivascular astrocytes.
Journal ArticleDOI
Cloning and sequence of a cDNA coding for the human beta-migrating endothelial-cell-type plasminogen activator inhibitor.
TL;DR: A lambda gt11 expression library containing cDNA inserts prepared from human placental mRNA was screened immunologically using an antibody probe developed against the beta-migrating plasminogen activator inhibitor (beta-PAI) purified from cultured bovine aortic endothelial cells, indicating that the beta -PAI is a member of the serine proteinase inhibitor (serpin) superfamily.